Search icon

HLS Therapeutics (USA), Inc.

Company Details

Name: HLS Therapeutics (USA), Inc.
Jurisdiction: MISSISSIPPI
Business Type: Profit Corporation
Status: Good Standing
Effective Date: 04 Aug 2021 (4 years ago)
Business ID: 1297315
State of Incorporation: DELAWARE
Principal Office Address: 919 Conestoga Road, Building Three Suite 310Rosemont, PA 19010

Agent

Name Role Address
C. T. CORPORATION SYSTEM Agent 645 LAKELAND EAST DRIVE STE 101, FLOWOOD, MS 39232

Secretary

Name Role Address
Ryan C. Lennox Secretary 919 Conestoga Road, Building Three Suite 310, Rosemont, PA 19010

Chief Executive Officer

Name Role Address
Craig Millian Chief Executive Officer 919 Conestoga Road, Building Three Suite 310, Rosemont, PA 19010

Director

Name Role Address
Craig Millian Director 919 Conestoga Road, Building Three Suite 310, Rosemont, PA 19010

Chief Financial Officer

Name Role Address
John Hanna Chief Financial Officer 919 Conestoga Road, Building Three, Suite 310, Rosemont, PA 19010

Filings

Type Status Filed Date Description
Annual Report Filed 2025-02-13 Annual Report For HLS Therapeutics (USA), Inc.
Annual Report Filed 2024-02-01 Annual Report For HLS Therapeutics (USA), Inc.
Annual Report Filed 2023-02-04 Annual Report For HLS Therapeutics (USA), Inc.
Annual Report Filed 2022-03-11 Annual Report For HLS Therapeutics (USA), Inc.
Formation Form Filed 2021-08-04 Formation For HLS Therapeutics (USA), Inc.

Date of last update: 08 Apr 2025

Sources: Mississippi Secretary of State